Indocyanine green targeted micelles with improved stability for near-infrared image-guided photothermal tumor therapy

Nanomedicine

Volumn 10, Issue 3, 2015, Pages 361-373

  Yan, Lu ^a   Qiu, Liyan ^b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

2 ethyl 2 oxazoline; folate; indocyanine green; micelle; NIR imaging; photothermal therapy

Indexed keywords

COPOLYMER; FOLIC ACID; INDOCYANINE GREEN; POLY(2 ETHYL 2 OXAZOLINE) B POLY(EPSILON CAPROLACTONE); SOLVENT; UNCLASSIFIED DRUG; COLORING AGENT; MICELLE; POLY(2-ETHYL-2-OXAZOLINE); POLYAMINE; POLYCAPROLACTONE; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG UPTAKE; EVAPORATION; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; KB CELL LINE; MICELLE; MOUSE; NANOENCAPSULATION; NEAR INFRARED IMAGING SYSTEM; NEOPLASM; NONHUMAN; OPTICS; PARTICLE SIZE; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HYPERTHERMIC THERAPY; NEOPLASMS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLORING AGENTS; DRUG DELIVERY SYSTEMS; FOLIC ACID; HUMANS; HYPERTHERMIA, INDUCED; INDOCYANINE GREEN; MICE; MICELLES; NEOPLASMS; PHOTOTHERAPY; POLYAMINES; POLYESTERS;

EID: 84923555027     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.118     Document Type: Article

References (51)

1. Alander JT, Kaartinen I, Laakso A., et al. A review of indocyanine green fluorescent imaging in surgery. Int. J. Biomed. Imaging 2012 , 940585 (2012
2. Altinoglu EI, Russin TJ, Kaiser JM., et al. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. ACS Nano 2(10), 2075-2084 (2008
3. Ogawa M, Kosaka N, Choyke PL, Kobayashi H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res. 69(4), 1268-1272 (2009
4. Zheng X, Zhou F, Wu B, Chen WR, Xing D. Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injection. Mol. Pharm. 9(3), 514-522 (2012
5. Yu J, Javier D, Yaseen MA., et al. Self-Assembly synthesis, tumor cell targeting, and photothermal capabilities of antibody-coated indocyanine green nanocapsules. J. Am. Chem. Soc. 132(6), 1929-1938 (2010
6. Weissleder R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19(4), 316-317 (2001
7. Zheng X, Xing D, Zhou F, Wu B, Chen WR. Indocyanine green-containing nanostructure as near-infrared dual-functional targeting probes for optical imaging and photothermal therapy. Mol. Pharm. 8(2), 447-456 (2011
8. Saxena V, Sadoqi M, Shao J. Degradation kinetics of indocyanine green in aqueous solution. J. Pharm. Sci. 92(10), 2090-2097 (2003
9. Ott P. Hepatic elimination of indocyanine green with special reference to distribution kinetics and the influence of plasma protein binding. Pharmacol. Toxicol. 83(Suppl 2), 1-48 (1998
10. Kirchherr AK, Briel A, Mader K. Stabilization of indocyanine green by encapsulation within micellar systems. Mol. Pharm. 6(2), 480-491 (2009
11. Rudin M. Noninvasive structural, functional, and molecular imaging in drug development. Curr. Opin. Chem. Biol. 13(3), 360-371 (2009
12. Asanuma D, Kobayashi H, Nagano T, Urano Y. Fluorescence imaging of tumors with 'smart' pH-Activatable targeted probes. Methods Mol. Biol. 574, 47-62 (2009
13. Kim TH, Mount CW, Dulken BW., et al. Filamentous, mixed micelles of triblock copolymers enhance tumor localization of indocyanine green in a murine xenograft model. Mol. Pharm. 9(1), 135-143 (2012
14. Saxena V, Sadoqi M, Shao J. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release. Int. J. Pharm. 278(2), 293-301 (2004
15. Chen Y, Li X. Near-infrared fluorescent nanocapsules with reversible response to thermal/pH modulation for optical imaging. Biomacromolecules 12(12), 4367-4372 (2011
16. Mattheolabakis G, Rigas B, Constantinides PP. Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. Nanomedicine (Lond.) 7(10), 1577-1590 (2012
17. Tu Q, Zhang Y, Liu R., et al. Active drug targeting of disease by nanoparticles functionalized with ligand to folate receptor. Curr. Med. Chem. 19(19), 3152-3162 (2012
18. Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56(11), 1649-1659 (2004
19. Estevez MC, Huang YF, Kang H., et al. Nanoparticle-Aptamer conjugates for cancer cell targeting and detection. Methods Mol. Biol. 624, 235-248 (2010
20. Wu L, Fang S, Shi S, Deng J, Liu B, Cai L. Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study. Biomacromolecules 14(9), 3027-3033 (2013
21. Wang X, Li X, Li Y., et al. Synthesis, characterization and biocompatibility of poly(2-ethyl-2-oxazoline)-poly(d,l-lactide)-poly(2-ethyl-2-oxazoline) hydrogels. Acta Biomater. 7(12), 4149-4159 (2011
22. Zalipsky S, Hansen CB, Oaks JM, Allen TM. Evaluation of blood clearance rates and biodistribution of poly(2- oxazoline)-grafted liposomes. J. Pharm. Sci. 85(2), 133-137 (1996
23. Bauer M, Lautenschlaeger C, Kempe K, Tauhardt L, Schubert US, Fischer D. Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and hemocompatibility. Macromol. Biosci. 12(7), 986-998 (2012
24. Mero A, Pasut G, Dalla VL., et al. Synthesis and characterization of poly(2-ethyl-2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates?. J. Control. Release 125(2), 87-95 (2008
25. Hsiue GH, Chiang HZ, Wang CH, Juang TM. Nonviral gene carriers based on diblock copolymers of poly(2-ethyl- 2-oxazoline) and linear polyethylenimine. Bioconjug. Chem. 17(3), 781-786 (2006
26. Yang Y, Kataoka K, Winnik F. Synthesis of diblock copolymers consisting of Hyaluronan and poly(2-ethyl-2- oxazoline). Macromolecules 38(6), 2043-2046 (2005
27. Luxenhofer R, Han Y, Schulz A., et al. Poly(2-oxazoline)s as polymer therapeutics. Macromol. Rapid Commun. 33(19), 1613-1631 (2012
28. Hsiue GH, Wang CH, Lo CL, Wang CH, Li JP, Yang JL. Environmental-sensitive micelles based on poly(2-ethyl- 2-oxazoline)-b-poly(L-lactide) diblock copolymer for application in drug delivery. Int. J. Pharm. 317(1), 69-75 (2006
29. Wang CH, Wang CH, Hsiue GH. Polymeric micelles with a pH-responsive structure as intracellular drug carriers. J. Control. Release 108(1), 140-149 (2005
30. Fernandes JC, Qiu X, Winnik FM., et al. Linear polyethylenimine produced by partial acid hydrolysis of poly(2-ethyl-2-oxazoline) for DNA and siRNA delivery in vitro. Int. J. Nanomedicine 8, 4091-4102 (2013
31. de la Rosa VR. Poly(2-oxazoline)s as materials for biomedical applications. J. Mater. Sci. Mater. Med. 25(5), 1211-1225 (2014
32. Vlahov IR, Leamon CP. Engineering folate-drug conjugates to target cancer: from chemistry to clinic. Bioconjug. Chem. 23(7), 1357-1369 (2012
33. Workman P, Aboagye EO, Balkwill F., et al. Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer 102(11), 1555-1577 (2010
34. Qiu LY, Yan L, Zhang L, Jin YM, Zhao QH. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery. Int. J. Pharm. 456, 315-324 (2013
35. Kim TH, Chen Y, Mount CW, Gombotz WR, Li X, Pun SH. Evaluation of temperature-sensitive, indocyanine green-encapsulating micelles for noninvasive near-infrared tumor imaging. Pharm. Res. 27(9), 1900-1913 (2010
36. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338(2), 284-293 (2005
37. Podechard N, Tekpli X, Catheline D., et al. Mechanisms involved in lipid accumulation and apoptosis induced by 1-nitropyrene in Hepa1c1c7 cells. Toxicol. Lett. 206(3), 289-299 (2011
38. Kabakov AE, Kudryavtsev VA, Gabai VL. Determination of cell survival or death. Methods Mol. Biol. 787, 231-244 (2011
39. Rodriguez VB, Henry SM, Hoffman AS, Stayton PS, Li X, Pun SH. Encapsulation and stabilization of indocyanine green within poly(styrene-Alt-maleic anhydride) block-poly(styrene) micelles for near-infrared imaging. J. Biomed. Opt. 13(1), 14025 (2008
40. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5(4), 505-515 (2008
41. Harmon BV, Corder AM, Collins RJ., et al. Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int. J. Radiat. Biol. 58(5), 845-858 (1990
42. O'Neill KL, Fairbairn DW, Smith MJ, Poe BS. Critical parameters influencing hyperthermia-induced apoptosis in human lymphoid cell lines. Apoptosis 3(5), 369-375 (1998
43. Zhou J, Wang X, Du L., et al. Effect of hyperthermia on the apoptosis and proliferation of CaSki cells. Mol. Med. Rep. 4(1), 187-191 (2011
44. Liang H, Zhan HJ, Wang BG, Pan Y, Hao XS. Change in expression of apoptosis genes after hyperthermia, chemotherapy and radiotherapy in human colon cancer transplanted into nude mice. World J. Gastroenterol. 13(32), 4365-4371 (2007
45. Moulin M, Arrigo AP. Caspases activation in hyperthermia-induced stimulation of TRAIL apoptosis. Cell Stress Chaperones 13(3), 313-326 (2008
46. Ko S, Yuen WF, Fung KP., et al. Reversal of TNF-Alpha resistance by hyperthermia: role of mitochondria. Life Sci. 67(25), 3113-3121 (2000
47. Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat. Rev. Cancer 14(3), 199-208 (2014
48. Burke AR, Singh RN, Carroll DL., et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials 33(10), 2961-2970 (2012
49. Liu Y, Cho CW, Yan X., et al. Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells. Pharm. Res. 18(9), 1255-1261 (2001
50. Hongyan Zhu, Dawei Deng, Haiyan Chen, Zhiyu Qian, Yueqing Gu. The targeted behavior of folate-decorated N-succinyl-N'-octyl chitosan evaluated by NIR system in mouse model. Proc. SPIE 7845, 78452D (2010
51. Intes X. Time-domain optical mammography SoftScan: initial results. Acad. Radiol. 12(8), 934-947 (2005